Abstract
Neutrophil elastase and myeloperoxidase enzymes have been implicated in high-fat diet-induced obesity, insulin resistance (IR) and atherosclerosis in animal models. The aim of the present study was to explore neutrophil elastase and myeloperoxidase mRNA expressions in the peripheral blood leukocytes (PBL) in overweight and obese subjects, and to correlate those mRNA expressions with BMI, IR and cardiovascular biomarkers. In this cross-sectional study, 74 apparently healthy subjects including 22 lean, 27 overweight and 25 obese subjects were recruited. Cardiovascular and metabolic biomarkers were evaluated from fasting blood samples. The mRNA levels of neutrophil elastase and myeloperoxidase genes in the PBL were quantified by real-time PCR. Compared to lean group, the overweight and obese groups showed significant upregulation of both neutrophil elastase (p < 0.001) and myeloperoxidase (p < 0.03) mRNA expressions in the PBL. But no difference was found between overweight and obese groups. The neutrophil elastase and myeloperoxidase mRNA levels showed significant positive correlation with BMI, serum triglyceride, atherogenic index of plasma and 10-year risk of developing cardiovascular disease. But no correlation was found with glucose, insulin or IR. It was concluded that the neutrophil elastase and myeloperoxidase genes are up-regulated in both overweight and obese subjects and are associated with BMI and markers of cardiovascular disease.
Similar content being viewed by others
References
Caielli S, Banchereau J, Pascual V (2012) Neutrophils come of age in chronic inflammation. Curr Opin Immunol 24:671–677
Pinegin B, Vorobjeva N, Pinegin V (2015) Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity. Autoimmun Rev 14:633–640
Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V (2015) Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 349:316–320
Elgazar-Carmon V, Rudich A, Hadad N, Levy R (2008) Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 49:1894–1903
Talukdar S, Oh DY, Bandyopadhyay G et al (2012) Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 18:1407–1412
Kawanishi N, Niihara H, Mizokami T, Yada K, Suzuki K (2015) Exercise training attenuates neutrophil infiltration and elastase expression in adipose tissue of high-fat-diet-induced obese mice. Physiol Rep 3:e12534. https://doi.org/10.14814/phy2.12534
Michishita R, Shono N, Inoue T, Tsuruta T, Node K (2010) Effect of exercise therapy on monocyte and neutrophil counts in overweight women. Am J Med Sci 339:152–156
Wang Q, Xie Z, Zhang W et al (2014) Myeloperoxidase deletion prevents high-fat diet-induced obesity and insulin resistance. Diabetes 63:4172–4185
McMillen TS, Heinecke JW, LeBoeuf RC et al (2005) Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 111:2798–2804
Mansuy-Aubert V, Zhou QL, Xie X et al (2013) Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metab 17:534–548
Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A (2010) Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191:677–691
Nijhuis J, Rensen SS, Slaats Y, van Dielen FM, Buurman WA, Greve JW (2009) Neutrophil activation in morbid obesity, chronic activation of acute inflammation. Obesity 17:2014–2018
Xu X, Su S, Wang X et al (2015) Obesity is associated with more activated neutrophils in African American male youth. Int J Obes 39:26–32
Saab KR, Kendrick J, Yracheta JM, Lanaspa MA, Pollard M, Johnson RJ (2015) New insights on the risk for cardiovascular disease in African Americans: the role of added sugars. J Am Soc Nephrol 26:247–257
WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163
Dobiásová M, Frohlich J (2001) The plasma parameter log [TG/HDL-C] as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma [FER[HDL]]. Clin Biochem 34:583–588
D’Agostino RB Sr, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743–753
Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool [REST] for group-wise comparison and statistical analysis of relative expression results in real time PCR. Nucleic Acids Res 30:e36
Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53:1925–1932
Afshin A, Forouzanfar MH, Reitsma MB et al (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377:13–27
Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445
Nishimura S, Manabe I, Nagasaki M et al (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15:914–920
Hindle AK, Koury J, McCaffrey T, Fu SW, Brody F (2009) Dysregulation of gene expression within the peroxisome proliferator activated receptor pathway in morbidly obese patients. Surg Endosc 23:1292–1297
Ghosh S, Dent R, Harper ME, Gorman SA, Stuart JS, McPherson R (2010) Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity. BMC Med Genomics 3:56
Wiersma JJ, Meuwese MC, van Miert JN et al (2008) Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Med Sci Monit 14:CR406–CR410
Gómez García A, Rivera Rodríguez M, Gómez Alonso C, Rodríguez Ochoa DY, Alvarez Aguilar C (2015) Myeloperoxidase is associated with insulin resistance and inflammation in overweight subjects with first-degree relatives with type2 diabetes mellitus. Diabetes Metab J 39:59–65
Piwowar A, Knapik-Kordecka M, Warwas M (2000) Concentration of leukocyte elastase in plasma and polymorphonuclear neutrophil extracts in type 2 diabetes. Clin Chem Lab Med 38:1257–1261
Fadini GP, Menegazzo L, Rigato M et al (2016) NETosis delays diabetic wound healing in mice and humans. Diabetes 65:1061–1071
Wang Y, Xiao Y, Zhong L et al (2014) Increased neutrophil elastase and proteinase3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes. Diabetes 63:4239–4248
Sato N, Shimizu H, Suwa K, Shimomura Y, Kobayashi I, Mori M (1992) MPO activity and generation of active O2 species in leukocytes from poorly controlled diabetic patients. Diabetes Care 15:1050–1052
Unubol M, Yavasoglu I, Kacar F et al (2015) Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type2 diabetes. Diabetol Metab Syndr 7:119
Qin J, Fu S, Speake C, Greenbaum CJ, Odegard JM (2016) NETosis-associated serum biomarkers are reduced in type1 diabetes in association with neutrophil count. Clin Exp Immunol 184:318–322
Andrade VL, Petruceli E, Belo VA et al (2012) Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women. Clin Biochem 45:412–415
Borato DC, Parabocz GC, Ribas JT et al (2016) Biomarkers in obesity: serum myeloperoxidase and traditional cardiac risk parameters. Exp Clin Endocrinol Diabetes 124:49–54
Olza J, Aguilera CM, Gil-Campos M et al (2012) Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children. Diabetes Care 35:2373–2376
Correia-Costa L, Sousa T, Morato M et al (2016) Association of myeloperoxidase levels with cardiometabolic factors and renal function in prepubertal children. Eur J Clin Invest 46:50–59
Chhezom K, Arslan MI, Hoque MM, Biswas SK (2017) Biomarkers of cardiovascular and metabolic diseases in otherwise healthy overweight subjects in Bangladesh. Diabetes Metab Syndr 11:S381–S384
Franssens BT, van der Graaf Y, Kappelle LJ et al (2015) Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort study. Diabetes Care 38:1945–1951
Funghetto SS, Silva Ade O, de Sousa NM et al (2015) Comparison of percentage body fat and body mass index for the prediction of inflammatory and atherogenic lipid risk profiles in elderly women. Clin Interv Aging 10:247–253
Loprinzi PD, Crespo CJ, Andersen RE, Smit E (2015) Association of body mass index with cardiovascular disease biomarkers. Am J Prev Med 48:338–344
Gómez-Ambrosi J, Silva C, Galofré JC et al (2012) Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) 36:286–294
Guo X, Li Z, Guo L et al (2014) An update on overweight and obesity in rural Northeast China: from lifestyle risk factors to cardiometabolic comorbidities. BMC Public Health 14:1046
Acknowledgements
This study was partly supported by the Higher Education Quality Enhancement Project (HEQEP CP-3073) of the University Grants Commission, Bangladesh; Bangladesh Medical Research Council (BMRC); and Unimed Limited. We would like to thank Dr. Md. Masum Alam, Kazi Tahsin Ahmed and Hosneara Akter for technical and administrative assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they do not have conflict of interest.
Informed consent
Informed written consent was taken from all participants.
Research involving human participants
This research involves human participants.
Rights and permissions
About this article
Cite this article
Ali, M., Jasmin, S., Fariduddin, M. et al. Neutrophil elastase and myeloperoxidase mRNA expression in overweight and obese subjects. Mol Biol Rep 45, 1245–1252 (2018). https://doi.org/10.1007/s11033-018-4279-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-018-4279-4